FDA launches pilot program to accelerate rare disease therapies, improving communication between sponsors and FDA staff. #RareDiseaseTherapies #FDA #ClinicalTrials
FDA releases draft recommendations to modernize clinical trials, incorporating RWE, technology, and increasing diversity.
FDA supports DCTs, increasing accessibility, diversity, and efficiency in medical research.
